Decheng Capital’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-56,350
Closed -$1.88M – 30
2024
Q3
$1.88M Buy
+56,350
New +$1.94M 0.44% 20

Decheng Capital's LBPH Position: Q4 2024 in Review

Decheng Capital sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 56,350 shares — an estimated $1.88M sold.

Decheng Capital first reported a position in LBPH in Q3 2024 and held it in 1 quarter. The position peaked at $1.88M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

  • Decheng Capital reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Decheng Capital sold 56,350 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $1.88M.
  • Decheng Capital first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q3 2024 and held it in 1 quarter.
  • Decheng Capital's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $1.88M in Q3 2024.
  • 0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Decheng Capital's 13F filing for Q4 2024, filed 14 Feb 2025.